學門類別
哈佛
- General Management
- Marketing
- Entrepreneurship
- International Business
- Accounting
- Finance
- Operations Management
- Strategy
- Human Resource Management
- Social Enterprise
- Business Ethics
- Organizational Behavior
- Information Technology
- Negotiation
- Business & Government Relations
- Service Management
- Sales
- Economics
- Teaching & the Case Method
最新個案
- A practical guide to SEC ï¬nancial reporting and disclosures for successful regulatory crowdfunding
- Quality shareholders versus transient investors: The alarming case of product recalls
- The Health Equity Accelerator at Boston Medical Center
- Monosha Biotech: Growth Challenges of a Social Enterprise Brand
- Assessing the Value of Unifying and De-duplicating Customer Data, Spreadsheet Supplement
- Building an AI First Snack Company: A Hands-on Generative AI Exercise, Data Supplement
- Building an AI First Snack Company: A Hands-on Generative AI Exercise
- Board Director Dilemmas: The Tradeoffs of Board Selection
- Barbie: Reviving a Cultural Icon at Mattel (Abridged)
- Happiness Capital: A Hundred-Year-Old Family Business's Quest to Create Happiness
World Health Organization: Facilitating COVID-19 Vaccines for the World
內容大綱
On May 29, 2020, the World Health Organization launched the COVID-19 Technologies Access Pool (C-TAP) with the aim of making pandemic-related technologies-specifically, vaccines and treatments-available to its participants. Although the initiative was positively received in many developing countries, it was not well received by pharmaceutical companies, who viewed C-TAP as a threat to the patent system and, therefore, as a threat to the companies' future research and development. Many non-governmental organizations (NGOs) supported the initiative because it was expected to help poorer countries and income groups access a vaccine. Companies, NGOs, and national governments had to decide how to engage in the process.